Panbela Therapeutics, Inc. (PBLA) has disclosed a new risk, in the Regulation category.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Panbela Therapeutics, Inc. faces a significant business risk due to its possible classification as a “penny stock” issuer. This classification can strip the company of the statutory safe harbor protections federal securities laws offer for forward-looking statements. Without this safeguard, Panbela may encounter increased vulnerability in legal proceedings that challenge the accuracy of its future-oriented representations. Such exposure could detrimentally impact the company’s financial health and the valuation of its common stock.
Overall, Wall Street has a Hold consensus rating on PBLA stock based on 1 Hold.
To learn more about Panbela Therapeutics, Inc.’s risk factors, click here.
